Collectively, these results suggest that ROS detoxification, mitochondrial metabolism, and DNA repair contribute to DNR tolerance in RHI-1 cells and in previously reported FLT3 wild-type [28], pediatric/adult [29], and FLT3 wild-type R/R AML patient cells. Here, FLT3 is linked to acute myeloid leukemia.